Company Filing History:
2 out of 16,338 
1 out of 259 
1 out of 1 
Years Active: 1990-2007
Title: Elizabeth Sally Ward: Innovator in Immunology
Introduction
Elizabeth Sally Ward is a prominent inventor based in Cambridge, GB. She has made significant contributions to the field of immunology, particularly through her innovative work on single domain ligands and receptors. With a total of 5 patents to her name, her inventions have the potential to impact therapy, diagnosis, and catalysis.
Latest Patents
Her latest patents focus on single domain ligands derived from molecules in the immunoglobulin (Ig) superfamily. These patents detail receptors that comprise at least one such ligand, along with methods for cloning, amplifying, and expressing DNA sequences encoding these ligands. The preferred method for this process is the polymerase chain reaction. Additionally, her patents cover the use of these DNA sequences in the production of Ig-type molecules, as well as the application of these ligands or receptors in various therapeutic and diagnostic contexts.
Career Highlights
Throughout her career, Elizabeth has worked with notable organizations, including E.I. DuPont De Nemours and Company and the Medical Research Council. Her work has been instrumental in advancing the understanding and application of immunological concepts.
Collaborations
Elizabeth has collaborated with esteemed colleagues such as Gregory Paul Winter and Detlef Güssow. These partnerships have further enriched her research and innovation in the field.
Conclusion
Elizabeth Sally Ward's contributions to immunology through her patents and collaborations highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in therapy and diagnosis.